Subependymomas are rare, slow-growing benign neoplasms. Although most are asymptomatic, they can present with symptoms related to increased intracranial pressure and hydrocephalus. We describe a 47-year-old man with worsening headaches who was found to have a subependymoma, with a focus on the imaging findings, differential diagnoses, pathology, and treatment.
CASE REPORT
A 47-year-old man, who previously had undergone gastric bypass for morbid obesity, presented to his neurologist complaining of headaches for 3 years, with major worsening of their frequency and severity for 2 weeks. Th e headaches now involved his entire head and were only transiently relieved with over-the-counter analgesics.
Magnetic resonance imaging (MRI) of his brain was obtained and revealed an extraaxial mass in the inferior fourth ventricle extending through the foramen magnum and impressing upon the pontomedullary junction and medulla with posterior compression of the cerebellar tonsils. Th e mass had similar signal intensity to brain parenchyma on T1-weighted images and showed scattered heterogeneous enhancement (Figure 1) . Th e T2-weighted images revealed increased signal intensity relative to brain parenchyma and lack of adjacent edema (Figure 2) . A gradient echo sequence showed scattered foci of hypointensity indicating T 2 * susceptibility favoring the presence of calcifi c deposits and/or blood (Figure 3) .
Th e patient underwent a craniotomy with complete resection of the fourth ventricular mass (Figure 4 ). Histologic evaluation of the lesion confi rmed the diagnosis of subependymoma ( Figure 5 ). Th e patient was subsequently discharged from the hospital after an uneventful postoperative course.
DISCUSSION
Subependymomas account for about 1% of all intracranial neoplasms (1) . Th ey are slow growing and well circumscribed. While they usually arise in the fourth ventricle in adults (60%), they have also been described in the lateral and third ventricles as well as in the spinal cord (2) . Imaging characteristics commonly include a well-defi ned solid or less frequently mixed solid and cystic intraventricular mass. Th e solid component is isodense on computed tomography, isointense on T1-weighted images, and hyperintense on T2-weighted images. Peritumoral edema is usually not present. Lesions are typically 1 to 2 cm in diameter; however, tumors >5 cm have been described (2) . Enhancement characteristics are variable: they are most often absent, but mild to moderate and even intense enhancement has been described. Calcifi c deposits can be seen with larger tumors and are frequently a constituent of fourth ventricular subependymomas. Hemorrhage is rare (2-4) . Th e diff erential diagnosis of a subependymoma is an ependymoma, choroid plexus papilloma, central neurocytoma, subependymal giantcell astrocytoma, hemangioblastoma, cavernous malformation, and metastasis. In an individual of this age, and in the location of this mass with the given MRI features outlined above, the b a diagnosis of exclusion was a subependymoma with a less likely consideration being an ependymoma.
On gross examination, subependymomas have a white to gray color, are well circumscribed with a fi rm texture, and are usually avascular with an attachment to the ventricular wall by a narrow pedicle. Th ese lesions are thought to arise from subependymal glial cells, although other considerations include astrocytes from the subependymal plate, ependymal cells, and mixed ependymal and astrocytic cells (2, 5) . On histological examination, clusters of nuclei on a fi brillary background are seen. Immunohistochemical staining for glial fi brillary acidic protein is highly positive. Mitotic activity is typically minimal or absent, corresponding to a World Health Organization grade 1 lesion (2, 5) .
Th e treatment of choice for subependymomas is complete surgical resection, which yields an excellent prognosis with rare recurrences (2, 6) . A complete surgical resection is more commonly possible with lesions located in the lateral ventricles, with fourth ventricular locations often treated with subtotal resections. Th ere is little documented additional benefi t from chemotherapy or radiotherapy (2, 6) .
